Table 2.
Expression of 14 miRNAs in stage I NSCLC and normal lung tissues
| MiRNAs | Mean ± in normal tissues | Mean ± in SCC tissues | P | Mean ± in AC tissues | P |
|---|---|---|---|---|---|
| miR-577 | 0.01451 ± 0.003321 | 0.2515 ± 0.08886 | 0.019322136 | 0.5677 ± 0.1608 | 0.00164515 |
| miR-9-3p | 0.5848 ± 0.07936 | 1.145 ± 0.9148 | 0.181212245 | 4.406 ± 1.676 | 0.02148481 |
| miR-9-5p | 1.259 ± 0.3149 | 16.49 ± 4.287 | 0.001063353 | 24.80 ± 8.250 | 0.0047478 |
| miR-196a-5p | 2.537 ± 0.5663 | 10.70 ± 2.803 | 0.00690936 | 9.641 ± 3.711 | 0.04999313 |
| miR-184 | 3.914 ± 0.8641 | 0.2541 ± 0.06159 | 0.000144289 | 0.4388 ± 0.08817 | 0.00054774 |
| miR-182-3p | 0.04403 ± 0.006379 | 0.1417 ± 0.03219 | 0.006178624 | 0.2706 ± 0.05945 | 0.00042487 |
| miR-205-5p | 23.95 ± 5.303 | 308.1 ± 58.16 | 2.01882E-05 | 13.73 ± 3.180 | 0.11644956 |
| miR-147b | 0.1172 ± 0.02934 | 0.3063 ± 0.05407 | 0.003199587 | 0.1709 ± 0.03255 | 0.22830513 |
| miR-183-3p | 2.646 ± 0.2470 | 5.881 ± 1.235 | 0.010504173 | 2.890 ± 0.5396 | 0.68328771 |
| miR-944 | 0.03953 ± 0.004614 | 0.1930 ± 0.03721 | 0.000300373 | 0.05165 ± 0.01756 | 0.49885518 |
| miR-135a-5p | 22.25 ± 5.083 | 1.779 ± 0.5716 | 0.000281447 | 5.075 ± 1.148 | 0.00340084 |
| miR-205-3p | 0.03880 ± 0.02018 | 0.3976 ± 0.09866 | 0.001312184 | 0.02559 ± 0.008623 | 0.56756265 |
| miR-486-5p | 228.0 ± 41.94 | 13.15 ± 8.543 | 1.24895E-05 | 9.225 ± 1.659 | 1.812E-05 |
| miR-30a-3p | 350.9 ± 53.31 | 20.22 ± 7.034 | 3.54479E-07 | 26.16 ± 4.965 | 1.4943E-06 |
NSCLC, non-small cell lung cancer; SCC, squamous cell carcinoma; AC, adenocarcinoma; SD, standard deviation.